Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVACC: Vasopressin vs Noradrenaline in Cardiac Surgery
NCT05568160Phase 3Active, not recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Jan 2023
- Primary completion
- Mar 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of vasopressin in vasoplegic syndrome (VPS), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Jan 2023; status: active, not recruiting.
02
Drugs
vasopressin
03
Conditions
vasoplegic syndrome (VPS)
Beyond the preview
Go deeper on NCT05568160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05568160.